Rectal adenocarcinoma: Which Medications Cause It? (516 Reports Across 56 Drugs)
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Rectal adenocarcinoma has been reported as an adverse event with 56 different drugs in the FDA's FAERS database, with 516 total reports. 78 of these reports resulted in death.The drugs most commonly associated with Rectal adenocarcinoma are LENALIDOMIDE, DEXAMETHASONE, and BEVACIZUMAB.
516
Total Reports
56
Drugs Involved
78
Deaths
199
Hospitalizations
61.5 yrs
Average Patient Age
42.6% / 57.4%
Female / Male
Which Drugs Cause Rectal adenocarcinoma Most Often?
| Drug | Reports | % of Drug Reports | Deaths | Hosp. | Life-Threat. |
|---|---|---|---|---|---|
| LENALIDOMIDE | 55 | 0.0% | 9 | 17 | 11 |
| DEXAMETHASONE | 46 | 0.0% | 11 | 18 | 9 |
| BEVACIZUMAB | 40 | 0.1% | 8 | 5 | 4 |
| ADALIMUMAB | 39 | 0.0% | 4 | 13 | 3 |
| FLUOROURACIL | 36 | 0.1% | 4 | 10 | 1 |
| OXALIPLATIN | 34 | 0.1% | 3 | 10 | 1 |
| LEUCOVORIN | 27 | 0.1% | 2 | 5 | 1 |
| ETANERCEPT | 25 | 0.0% | 2 | 10 | 1 |
| INFLIXIMAB | 25 | 0.0% | 1 | 10 | 0 |
| PANITUMUMAB | 22 | 0.2% | 3 | 9 | 1 |
| METHOTREXATE | 21 | 0.0% | 1 | 7 | 1 |
| IRINOTECAN | 20 | 0.1% | 3 | 4 | 1 |
| CYCLOPHOSPHAMIDE | 19 | 0.0% | 4 | 5 | 3 |
| RITUXIMAB | 19 | 0.0% | 1 | 5 | 0 |
| USTEKINUMAB | 18 | 0.0% | 2 | 8 | 2 |
| THALIDOMIDE | 17 | 0.1% | 1 | 10 | 3 |
| BORTEZOMIB | 16 | 0.0% | 4 | 6 | 3 |
| VEDOLIZUMAB | 15 | 0.0% | 2 | 4 | 4 |
| RANITIDINE | 13 | 0.0% | 4 | 1 | 0 |
| CETUXIMAB | 12 | 0.1% | 0 | 0 | 0 |